The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors.

In December 2025, FDA posted an early alert that Abbott Diabetes Care was recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to incorrectly low glucose readings. Since then, Abbott has reported an additional 124 adverse events, totaling 860 serious injuries and seven deaths as of January 7, 2026. No additional deaths have been reported since November 14, 2025, and none of those were in the US.

The affected products haven’t changed, but the list of affected lots has been modified for clarity. They are:

FreeStyle Libre 3 Sensor

• Model Numbers: 72081-01, 72080-01
• Unique Device Identifiers (UDI-DI): 00357599818005, 00357599819002

FreeStyle Libre 3 Plus Sensor

• Model Numbers: 78768-01, 78769-01
• UDI-DI: 00357599844011, 00357599843014

FreeStyle Libre 3 readers and mobile apps are not affected, nor are any other Libre products (FreeStyle Libre 14 day, FreeStyle Libre 2, FreeStyle Libre 2 Plus, or Libre Pro sensors) or Abbott biowearables.

The following advice to clinicians remains the same:

• Inform your patients of the issue and instruct them to visit www.FreeStyleCheck.com to confirm whether their sensors are affected. Abbott Diabetes Care has provided a patient letter to use with your patients.
• If your patient is currently wearing or has a FreeStyle Libre 3 or Libre 3 Plus sensor that has been confirmed as potentially affected on that link or by a customer service representative, have them immediately discontinue use and dispose of the affected sensor(s).
• Patients can request a replacement for any potentially affected sensor(s) on www.FreeStyleCheck.com, by selecting “CONFIRM SENSOR SERIAL NUMBER” and entering a valid serial number. If their sensor is potentially affected, they will be instructed to enter their contact information so a replacement product can be sent to them at no cost.
• Patients can use a blood glucose meter or the built-in meter in the FreeStyle Libre 3 Reader to make treatment decisions when sensor readings don’t match symptoms or expectations.
• Sales representatives will contact clinicians with instructions to dispose of impacted samples. Sample replacements will be sent.

Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape, with other work appearing in the Washington Post, NPR’s Shots blog, and Diatribe. She is on X @MiriamETucker and BlueSky @miriametucker.bsky.social.